1. Inhibition of p42 MAPK using a nonviral vector-delivered siRNA potentiates the anti-tumor effect of metformin in prostate cancer cells. (April 2012) Authors: Monteagudo, Silvia; Pérez-Martínez, Francisco C; Pérez-Carrión, María D; Guerra, Javier; Merino, Sonia; Sánchez-Verdú, María Prado; Ceña, Valentín Journal: Nanomedicine Issue: Volume 7:Number 4(2012) Page Start: 493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Nanoparticles for brain-specific drug and genetic material delivery, imaging and diagnosis. (April 2016) Authors: Posadas, Inmaculada; Monteagudo, Silvia; Ceña, Valentín Journal: Nanomedicine Issue: Volume 11:Number 7(2016) Page Start: 833 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Promising targets for therapy of osteoarthritis: a review on the Wnt and TGF-β signalling pathways. (April 2021) Authors: Cherifi, Chahrazad; Monteagudo, Silvia; Lories, Rik J. Journal: Therapeutic advances in musculoskeletal disease Issue: Volume 13(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Suramin increases cartilage proteoglycan accumulation in vitro and protects against joint damage triggered by papain injection in mouse knees in vivo. Issue 2 (30th November 2017) Authors: Guns, Laura-An; Monteagudo, Silvia; Kvasnytsia, Maryna; Kerckhofs, Greet; Vandooren, Jennifer; Opdenakker, Ghislain; Lories, Rik J; Cailotto, Frederic Journal: RMD open Issue: Volume 3:Issue 2(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Wnt signaling as target for the treatment of osteoarthritis. Issue 5 (October 2017) Authors: Stampella, Alessandra; Monteagudo, Silvia; Lories, Rik Journal: Best practice & research Issue: Volume 31:Issue 5(2017:Oct.) Page Start: 721 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗